RxDoctor Payments Data

Henry Allen

Internal Medicine · Jonesboro, ARNPI 1063478493

Payments from drug & device makers

$1,502in general payments, 2019–2025

Across 104 payments — averaging $14.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$351
  • Sunovion Pharmaceuticals Inc.$169
  • Pfizer$160
  • GSK$148
  • Boehringer Ingelheim$107
  • AstraZeneca$79
  • plus $489 from 15 others

What the payments were for

  • Food & beverage$1,502100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,502 in reported general payments places this provider in the 75th percentile of 614 internal medicine providers in Arkansas.

See all internal medicine providers in Arkansas

Most prescribed under Part D

DrugClaimsCost to plans & patients
EnbrelEtanercept14$101,422
OzempicSemaglutide67$76,204
JardianceEmpagliflozin40$36,526
EliquisApixaban41$29,509
Trelegy ElliptaFluticasone/Umeclidin/Vilanter18$12,982
JanuviaSitagliptin Phosphate15$11,140
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen469$8,752
FarxigaDapagliflozin Propanediol14$8,434
EntrestoSacubitril/Valsartan11$7,936
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog12$6,788
Tresiba Flextouch U-100Insulin Degludec12$6,261
SymbicortBudesonide/Formoterol Fumarate12$5,309
Breo ElliptaFluticasone/Vilanterol12$4,937
Albuterol Sulfate HfaAlbuterol Sulfate121$3,744
Gabapentin250$3,444

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AmgenEnbrel$31$101,42214 claims
Novo NordiskOzempic$15$76,20467 claims
Boehringer IngelheimJardiance$107$36,52640 claims
PfizerEliquis$160$29,50941 claims
GSKTrelegy Ellipta, Breo Ellipta$148$17,91930 claims
AstraZenecaFarxiga, Symbicort$79$13,74326 claims
MerckJanuvia$78$11,14015 claims
NovartisEntresto$16$7,93611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 614 internal medicine providers in Arkansas.

Other internal medicine in Jonesboro

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →